Bioventus Inc. Canaccord Genuity Musculoskeletal Conference – May 20, 2021 @bioventus® Disclaimer Forward-Looking Information This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this presentation that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements c ...

@bioventus® Innovations For Active Healing Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this presentation that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements concerning our industry, competitive position and the mar ...

Bioventus, Inc. (NASDAQ:BVS) Q1 2021 Earnings Conference Call May 12, 2021 5:00 PM ET Company Participants Ken Reali - CEO Greg Anglum - CFO Conference Call Participants Drew Ranieri - Morgan Stanley Amit Hazan - Goldman Sachs Kyle Rose - Canaccord Operator Good afternoon, and welcome to the First Quarter 2021 Earnings Conference Call for Bioventus Inc. [Operator Instructions] Please note that this call is being recorded and that the recording will be available on the company's website for replay shortly. B ...

Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________ FORM 10-K _______________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ . Commission File Number: 001-37844 _______________________ Bioventus Inc. (Exact ...